SIBOLD WILLIAM JOHN (President and CEO) sold 6.5% of their position (7.62K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.05M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/21/2025ACC: 0001518611-25-000007
DirectorOfficer· President and CEO
Since Mar 2026
-7.62K
Net shares
Net seller
$3.05M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.49K
Price / share
$400.03
Trade value
$2.59M
% of position
5.5%
8/21/2025
117.37K→110.88K
Common Stock
Direct
Shares
−1.13K
Price / share
$401.00
Trade value
$453.53K
% of position
1.0%
8/21/2025
110.88K→109.75K
Total
Net shares
−7.62K
Net value
-$3.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | S · Sale | −6.49K | $400.03 | $2.59M | 5.5% | 117.37K | 110.88K |
| Common Stock Direct | 8/21/2025 | S · Sale | −1.13K | $401.00 | $453.53K | 1.0% | 110.88K | 109.75K |
| Total | −7.62K | -$3.05M | ||||||
Derivative Transactions0
No derivative transactions reported